142 related articles for article (PubMed ID: 35468444)
21. CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation.
Shan QY; Hu HT; Feng ST; Peng ZP; Chen SL; Zhou Q; Li X; Xie XY; Lu MD; Wang W; Kuang M
Cancer Imaging; 2019 Feb; 19(1):11. PubMed ID: 30813956
[TBL] [Abstract][Full Text] [Related]
22. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
[No Abstract] [Full Text] [Related]
23. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.
Zhou Y; He L; Huang Y; Chen S; Wu P; Ye W; Liu Z; Liang C
Abdom Radiol (NY); 2017 Jun; 42(6):1695-1704. PubMed ID: 28180924
[TBL] [Abstract][Full Text] [Related]
24. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
[TBL] [Abstract][Full Text] [Related]
25. Preoperative prediction of microvascular invasion of hepatocellular carcinoma using
Hyun SH; Eo JS; Song BI; Lee JW; Na SJ; Hong IK; Oh JK; Chung YA; Kim TS; Yun M
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):720-726. PubMed ID: 29167923
[TBL] [Abstract][Full Text] [Related]
26. Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma.
Ding GY; Ma JQ; Yun JP; Chen X; Ling Y; Zhang S; Shi JY; Chang YQ; Ji Y; Wang XY; Tan WM; Yuan KF; Yan B; Zhang XM; Liang F; Zhou J; Fan J; Zeng Y; Cai MY; Gao Q
J Hepatol; 2022 Mar; 76(3):608-618. PubMed ID: 34793865
[TBL] [Abstract][Full Text] [Related]
27. Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
Mulé S; Galletto Pregliasco A; Tenenhaus A; Kharrat R; Amaddeo G; Baranes L; Laurent A; Regnault H; Sommacale D; Djabbari M; Pigneur F; Tacher V; Kobeiter H; Calderaro J; Luciani A
Radiology; 2020 Jun; 295(3):562-571. PubMed ID: 32228294
[TBL] [Abstract][Full Text] [Related]
28. Imaging features based on Gd-EOB-DTPA-enhanced MRI for predicting vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma.
Fan Y; Yu Y; Hu M; Wang X; Du M; Guo L; Hu C
Br J Radiol; 2021 Mar; 94(1119):20200950. PubMed ID: 33417489
[TBL] [Abstract][Full Text] [Related]
29. Optimal criteria for hepatocellular carcinoma diagnosis using CT in patients undergoing liver transplantation.
Seo N; Kim MS; Park MS; Choi JY; An C; Han K; Kim SU; Joo DJ; Kim MJ
Eur Radiol; 2019 Feb; 29(2):1022-1031. PubMed ID: 29974221
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of a prediction model for microvascular invasion in hepatocellular carcinoma.
Wang L; Jin YX; Ji YZ; Mu Y; Zhang SC; Pan SY
World J Gastroenterol; 2020 Apr; 26(14):1647-1659. PubMed ID: 32327913
[TBL] [Abstract][Full Text] [Related]
31. Body Composition Changes in Hepatocellular Carcinoma: Prediction of Survival to Transcatheter Arterial Chemoembolization in Combination With Clinical Prognostic Factors.
Zheng X; Cao F; Qian L; Dong J
Cancer Control; 2021; 28():10732748211038445. PubMed ID: 34569304
[TBL] [Abstract][Full Text] [Related]
32. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma based on B-Mode US and CEUS.
Luo M; Liu X; Yong J; Ou B; Xu X; Zhao X; Liang M; Zhao Z; Ruan J; Luo B
Eur Radiol; 2023 Jun; 33(6):4024-4033. PubMed ID: 36484835
[TBL] [Abstract][Full Text] [Related]
33. Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.
Kang HJ; Kim H; Lee DH; Hur BY; Hwang YJ; Suh KS; Han JK
Radiology; 2021 Sep; 300(3):572-582. PubMed ID: 34227881
[TBL] [Abstract][Full Text] [Related]
34. Tertiary lymphoid structures in lung adenocarcinoma: characteristics and related factors.
Ren F; Xie M; Gao J; Wu C; Xu Y; Zang X; Ma X; Deng H; Song J; Huang A; Pang L; Qian J; Yu Z; Zhuang G; Liu S; Pan L; Xue X
Cancer Med; 2022 Aug; 11(15):2969-2977. PubMed ID: 35801360
[TBL] [Abstract][Full Text] [Related]
35. Preoperative prediction model for macrotrabecular-massive hepatocellular carcinoma based on contrast-enhanced CT and clinical characteristics: a retrospective study.
He C; Zhang W; Zhao Y; Li J; Wang Y; Yao W; Wang N; Ding W; Wei X; Yang R; Jiang X
Front Oncol; 2023; 13():1124069. PubMed ID: 37197418
[TBL] [Abstract][Full Text] [Related]
36. A novel nomogram to predict the local tumor progression after microwave ablation in patients with early-stage hepatocellular carcinoma: A tool in prediction of successful ablation.
An C; Wu S; Huang Z; Ni J; Zuo M; Gu Y; Zhang T; Huang J
Cancer Med; 2020 Jan; 9(1):104-115. PubMed ID: 31714685
[TBL] [Abstract][Full Text] [Related]
37. A nomogram based on multi-modal ultrasound for prediction of microvascular invasion and recurrence of hepatocellular carcinoma.
Zhong X; Peng J; Xie Y; Shi Y; Long H; Su L; Duan Y; Xie X; Lin M
Eur J Radiol; 2022 Jun; 151():110281. PubMed ID: 35395542
[TBL] [Abstract][Full Text] [Related]
38. The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and Prognosis of Patients With Breast Cancer.
Wang B; Liu J; Han Y; Deng Y; Li J; Jiang Y
Front Immunol; 2022; 13():868155. PubMed ID: 35664009
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of treatment response in hepatocellular carcinoma in the explanted liver with Liver Imaging Reporting and Data System version 2017.
Seo N; Kim MS; Park MS; Choi JY; Do RKG; Han K; Kim MJ
Eur Radiol; 2020 Jan; 30(1):261-271. PubMed ID: 31418085
[TBL] [Abstract][Full Text] [Related]
40. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
Zhu WS; Shi SY; Yang ZH; Song C; Shen J
World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]